Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Malignant Melanoma

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    October 2020
  1. BLEICHER J, Swords DS, Mali ME, McGuire L, et al
    Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
    J Surg Oncol. 2020 Oct 24. doi: 10.1002/jso.26214.
    PubMed     Abstract available


  2. LEE AY, Brady MS
    Neoadjuvant immunotherapy for melanoma.
    J Surg Oncol. 2020 Oct 1. doi: 10.1002/jso.26229.
    PubMed     Abstract available


    September 2020
  3. AIKEN TJ, Stahl CC, Schwartz PB, Barrett J, et al
    Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
    J Surg Oncol. 2020 Sep 16. doi: 10.1002/jso.26225.
    PubMed     Abstract available


    August 2020
  4. STAHLIE EHA, van der Hiel B, Stokkel MPM, Schrage YM, et al
    The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
    J Surg Oncol. 2020 Aug 11. doi: 10.1002/jso.26155.
    PubMed     Abstract available


  5. NEMIR S, Mericli AF, Adelman DM, Liu J, et al
    A reconstructive algorithm of oncologic defects of the upper trunk and shoulder girdle: Factors predicting complexity and outcomes.
    J Surg Oncol. 2020;122:283-292.
    PubMed     Abstract available


    July 2020
  6. NADLER A, Look Hong NJ, Alavi N, Abadir W, et al
    Lesional therapies for in-transit melanoma.
    J Surg Oncol. 2020 Jul 15. doi: 10.1002/jso.26121.
    PubMed     Abstract available


  7. HUANG K, Misra S, Lemini R, Chen Y, et al
    Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    J Surg Oncol. 2020 Jul 11. doi: 10.1002/jso.26119.
    PubMed     Abstract available


  8. DELMAN KA
    Minimally invasive inguinal lymphadenectomy.
    J Surg Oncol. 2020;122:96-98.
    PubMed     Abstract available


  9. CARR MJ, Sun J, Zager JS
    Isolated limb infusion: Institutional protocol and implementation.
    J Surg Oncol. 2020;122:99-105.
    PubMed     Abstract available


    May 2020
  10. MEDINA BD, Choi BH, Rodogiannis KG, Moran U, et al
    Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
    J Surg Oncol. 2020 May 22. doi: 10.1002/jso.25987.
    PubMed     Abstract available


    October 2019
  11. DEN HONDT M, Starr MW, Millett MC, Smyth J, et al
    Surgical management of the neck in patients with metastatic melanoma in parotid lymph nodes.
    J Surg Oncol. 2019 Oct 25. doi: 10.1002/jso.25732.
    PubMed     Abstract available


  12. CARMICHAEL H, King BBT, Friedman C, Torphy RJ, et al
    Frequency and implications of occipital and posterior auricular sentinel lymph nodes in scalp melanoma.
    J Surg Oncol. 2019 Oct 15. doi: 10.1002/jso.25715.
    PubMed     Abstract available


  13. FRIEDMAN C, Lyon M, Torphy RJ, Thieu D, et al
    A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    J Surg Oncol. 2019 Oct 10. doi: 10.1002/jso.25720.
    PubMed     Abstract available


    September 2019
  14. ZHOU AY, Wang DY, McKee S, Ye F, et al
    Correlates of response and outcomes with talimogene laherperpvec.
    J Surg Oncol. 2019;120:558-564.
    PubMed     Abstract available


    August 2019
  15. DECKERS EA, Wevers KP, Muller Kobold AC, Damude S, et al
    S-100B as an extra selection tool for FDG PET/CT scanning in follow-up of AJCC stage III melanoma patients.
    J Surg Oncol. 2019 Aug 29. doi: 10.1002/jso.25682.
    PubMed     Abstract available


  16. READ T, Lonne M, Sparks DS, David M, et al
    Response to Stahlie et al regarding "A systematic review and meta-analysis of locoregional treatments for in-transit melanoma".
    J Surg Oncol. 2019 Aug 22. doi: 10.1002/jso.25686.
    PubMed    


  17. STAHLIE EHA, Blankenstein SA, van Houdt WJ, Wouters MWJM, et al
    A systematic review and meta-analysis of locoregional treatments for in-transit melanoma.
    J Surg Oncol. 2019 Aug 22. doi: 10.1002/jso.25685.
    PubMed    


    July 2019
  18. SONG Y, Bruce AN, Fraker DL, Karakousis GC, et al
    Isolated limb perfusion and infusion in the treatment of melanoma and soft tissue sarcoma in the era of modern systemic therapies.
    J Surg Oncol. 2019 Jul 2. doi: 10.1002/jso.25600.
    PubMed     Abstract available


    June 2019
  19. O'NEILL CH, Scoggins CR
    Melanoma.
    J Surg Oncol. 2019 Jun 27. doi: 10.1002/jso.25604.
    PubMed     Abstract available


    March 2019
  20. BARTLETT EK
    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2019 Mar 24. doi: 10.1002/jso.25442.
    PubMed    


  21. PAVRI SN, Han G, Khan S, Han D, et al
    Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25445.
    PubMed     Abstract available


  22. KLEMEN ND, Han G, Leong SP, Kashani-Sabet M, et al
    Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25444.
    PubMed     Abstract available


  23. SINNAMON AJ, Neuwirth MG, Song Y, Schultz SM, et al
    Multispectral photoacoustic imaging for the detection of subclinical melanoma.
    J Surg Oncol. 2019 Mar 15. doi: 10.1002/jso.25447.
    PubMed     Abstract available


  24. CIANCIO F, Elia R, Nacchiero E, Perrotta RE, et al
    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2019 Mar 12. doi: 10.1002/jso.25443.
    PubMed    


    February 2019
  25. PEREZ MC, Sun J, Farley C, Han D, et al
    Management of intussusception in patients with melanoma.
    J Surg Oncol. 2019 Feb 7. doi: 10.1002/jso.25393.
    PubMed     Abstract available


  26. READ T, Lonne M, Sparks DS, David M, et al
    A systematic review and meta-analysis of locoregional treatments for in-transit melanoma.
    J Surg Oncol. 2019 Feb 7. doi: 10.1002/jso.25400.
    PubMed     Abstract available


    January 2019
  27. GERKEN ALH, Dobroschke J, Reissfelder C, Hetjens S, et al
    Tissue sealants for the prevention of lymphoceles after radical inguinal lymph node dissection in patients with melanoma: A systematic review and individual patient data meta-analysis.
    J Surg Oncol. 2019 Jan 23. doi: 10.1002/jso.25366.
    PubMed     Abstract available


  28. READ T, Fayers W, Thomas J, Wagels M, et al
    Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25373.
    PubMed     Abstract available


  29. BRADY MS
    Introduction: Melanoma seminar.
    J Surg Oncol. 2019;119:167.
    PubMed    


  30. BELLO DM
    Indications for the surgical resection of stage IV disease.
    J Surg Oncol. 2019;119:249-261.
    PubMed     Abstract available


  31. SPILLANE A, Hong A, Fogarty G
    Re-examining the role of adjuvant radiation therapy.
    J Surg Oncol. 2019;119:242-248.
    PubMed     Abstract available


  32. RACZ JM, Block MS, Baum CL, Jakub JW, et al
    Management of local or regional non-nodal disease.
    J Surg Oncol. 2019;119:187-199.
    PubMed     Abstract available


    December 2018
  33. LIU JY, Lowe M
    Neoadjuvant Treatments for Advanced Resectable Melanoma.
    J Surg Oncol. 2018 Dec 27. doi: 10.1002/jso.25352.
    PubMed     Abstract available


  34. CROMPTON JG, Gilbert E, Brady MS
    Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging.
    J Surg Oncol. 2018 Dec 21. doi: 10.1002/jso.25343.
    PubMed     Abstract available


  35. HYAMS DM, Cook RW, Buzaid AC
    Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.
    J Surg Oncol. 2018 Dec 12. doi: 10.1002/jso.25319.
    PubMed     Abstract available


  36. DESCHNER B, Wayne JD
    Follow-up of the melanoma patient.
    J Surg Oncol. 2018 Dec 12. doi: 10.1002/jso.25324.
    PubMed     Abstract available


  37. KANG R, Columbo JA, Trooboff SW, Servos MM, et al
    Receipt of sentinel lymph node biopsy for thin melanoma is associated with distance traveled for care.
    J Surg Oncol. 2018 Dec 3. doi: 10.1002/jso.25314.
    PubMed     Abstract available


    November 2018
  38. BARTLETT EK
    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25316.
    PubMed     Abstract available


  39. NICOLSON NG, Han D
    Desmoplastic melanoma.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25317.
    PubMed     Abstract available


  40. KWAK M, Farrow NE, Salama AKS, Mosca PJ, et al
    Updates in adjuvant systemic therapy for melanoma.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25298.
    PubMed     Abstract available


  41. SONG Y, Karakousis GC
    Melanoma of unknown primary.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25302.
    PubMed     Abstract available


    September 2018
  42. RONCATI L, Piscioli F
    Clinical decision-making in patients with different histogenetic subtypes of thin melanoma.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25200.
    PubMed    


  43. NUNES LF, Mendes GLQ, Koifman RJ
    Subungual melanoma: A retrospective cohort of 157 cases from Brazilian National Cancer Institute.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25242.
    PubMed     Abstract available


  44. BHUTIANI N, Egger ME, Stromberg AJ, Gershenwald JE, et al
    A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25193.
    PubMed     Abstract available


  45. KANATSIOS S, Melanoma Project M, Li Wai Suen CSN, Cebon JS, et al
    Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25138.
    PubMed     Abstract available


  46. ISAKSSON K, Nielsen K, Mikiver R, Nieweg OE, et al
    Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25208.
    PubMed     Abstract available


    August 2018
  47. LATCHANA N, DiVincenzo MJ, Regan K, Abrams Z, et al
    Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.
    J Surg Oncol. 2018 Aug 21. doi: 10.1002/jso.25163.
    PubMed     Abstract available


  48. GONZALEZ AB, Baum CL, Brewer JD, Arpey CJ, et al
    Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins.
    J Surg Oncol. 2018 Aug 16. doi: 10.1002/jso.25176.
    PubMed     Abstract available


  49. HEWITT DB, Merkow RP, DeLancey JO, Wayne JD, et al
    National practice patterns of completion lymph node dissection for sentinel node-positive melanoma.
    J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25160.
    PubMed     Abstract available


    June 2018
  50. BEVERIDGE J, Taher M, Zhu J, Mahmood MN, et al
    Staged margin-controlled excision (SMEX) for lentigo maligna melanoma in situ.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25109.
    PubMed     Abstract available


  51. ROBINSON EM, Rosenbaum BE, Zhang Y, Rogers R, et al
    Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25111.
    PubMed     Abstract available


    April 2018
  52. BOONE BA, Perkins S, Bandi R, Santos E, et al
    Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.
    J Surg Oncol. 2018;117:940-946.
    PubMed     Abstract available


  53. POSSO C, Delgado Anaya D, Aguilar Henao J, Velasquez Gaviria JM, et al
    Nasolabial propeller perforator flap: Anatomical study and case series.
    J Surg Oncol. 2018;117:1100-1106.
    PubMed     Abstract available


    March 2018
  54. READ TA, Smith A, Thomas J, David M, et al
    Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study.
    J Surg Oncol. 2018 Mar 12. doi: 10.1002/jso.24921.
    PubMed     Abstract available


  55. PUZA CJ, Josyula S, Terando AM, Howard JH, et al
    Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?
    J Surg Oncol. 2018 Mar 7. doi: 10.1002/jso.25025.
    PubMed     Abstract available


  56. PUSIOL T, Piscioli F
    Management of thin melanoma.
    J Surg Oncol. 2018 Mar 6. doi: 10.1002/jso.24863.
    PubMed    


  57. HUGHES T, Broucek J, Iodice G, Bommareddy PK, et al
    Metastasectomy following incomplete response to high-dose interleukin-2.
    J Surg Oncol. 2018;117:572-578.
    PubMed     Abstract available


    February 2018
  58. BRANDAO PHDM, Bertolli E, Doria-Filho E, Santos Filho IDAO, et al
    In transit sentinel node drainage as a prognostic factor for patients with cutaneous melanoma.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25023.
    PubMed     Abstract available


  59. LOOK HONG NJ
    Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care-Response to letter.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25006.
    PubMed    


  60. MARUCCIA M, Elia R, Nacchiero E, Vestita M, et al
    Reply to "melanoma pattern of care in ontario: A call for strategic alignment of multidisciplinary care)".
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.25007.
    PubMed    


    December 2017
  61. KARYDIS I, Gangi A, Wheater MJ, Choi J, et al
    Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
    J Surg Oncol. 2017 Dec 28. doi: 10.1002/jso.24956.
    PubMed     Abstract available


  62. SUN H, Gong L, Zhao G, Zhan H, et al
    Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24905.
    PubMed     Abstract available


  63. LOOK HONG NJ, Cheng SY, Baxter NN, Wright FC, et al
    Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24936.
    PubMed     Abstract available


  64. JAKUB JW, Racz JM, Hieken TJ, Gonzalez AB, et al
    Neoadjuvant systemic therapy for regionally advanced melanoma.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24939.
    PubMed     Abstract available


  65. LORIMER PD, Benham E, Walsh K, Han Y, et al
    Letter response: Reporting of mitotic rate in cutaneous melanoma.
    J Surg Oncol. 2017;116:960.
    PubMed    


  66. CHU BS, Koffi W, Hoehn RS, Ertel A, et al
    Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database.
    J Surg Oncol. 2017;116:1176-1184.
    PubMed     Abstract available


    November 2017
  67. HERBERT G, Karakousis GC, Bartlett EK, Zaheer S, et al
    Transected thin melanoma: Implications for sentinel lymph node staging.
    J Surg Oncol. 2017 Nov 30. doi: 10.1002/jso.24930.
    PubMed     Abstract available


  68. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    In reply: Management of thin melanoma.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24858.
    PubMed    


    July 2017
  69. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    The natural history of thin melanoma and the utility of sentinel lymph node biopsy.
    J Surg Oncol. 2017 Jul 17. doi: 10.1002/jso.24765.
    PubMed     Abstract available


    June 2017
  70. RONCATI L, Piscioli F, Pusiol T
    The importance of mitotic rate reporting in primary cutaneous melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24738.
    PubMed    


  71. SUH YC, Suh HP, Lee JS, Chang JS, et al
    Reconstruction using a perforator free flap after malignant melanoma resection of the ankle and foot.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24736.
    PubMed     Abstract available


  72. ZIPPEL D, Markel G, Shapira-Frommer R, Ben-Betzalel G, et al
    Perioperative BRAF inhibitors in locally advanced stage III melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24744.
    PubMed     Abstract available


  73. SINNAMON AJ, Neuwirth MG, Bartlett EK, Zaheer S, et al
    Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24743.
    PubMed     Abstract available


    May 2017
  74. OZAO-CHOY J, Nelson DW, Hiles J, Stern S, et al
    The prognostic importance of scalp location in primary head and neck melanoma.
    J Surg Oncol. 2017 May 22. doi: 10.1002/jso.24679.
    PubMed     Abstract available


    April 2017
  75. MADU MF, Schopman JHH, Berger DMS, Klop WMC, et al
    Clinical prognostic markers in stage IIIC melanoma.
    J Surg Oncol. 2017 Apr 15. doi: 10.1002/jso.24635.
    PubMed     Abstract available


    March 2017
  76. LORIMER PD, Benham EC, Walsh K, Han Y, et al
    Reporting of mitotic rate in cutaneous melanoma: A study using the national cancer data base.
    J Surg Oncol. 2017;115:281-286.
    PubMed     Abstract available


    February 2017
  77. FOOTE M, Read T, Thomas J, Wagels M, et al
    Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma.
    J Surg Oncol. 2017 Feb 23. doi: 10.1002/jso.24580.
    PubMed     Abstract available


    December 2016
  78. SPARKS DS, Read T, Lonne M, Barbour AP, et al
    Primary cutaneous melanoma of the scalp: Patterns of recurrence.
    J Surg Oncol. 2016 Dec 30. doi: 10.1002/jso.24535.
    PubMed     Abstract available


    September 2016
  79. LEE KT, Kim EJ, Lee DY, Kim JH, et al
    Surgical excision margin for primary acral melanoma.
    J Surg Oncol. 2016 Sep 19. doi: 10.1002/jso.24442.
    PubMed     Abstract available


  80. DINH KH, Harris AF, LaFemina J, Whalen GF, et al
    Advantages of day-before lymphoscintigraphy and undiluted methylene blue dye injections for sentinel lymph node biopsies for melanoma.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24432.
    PubMed     Abstract available


  81. FAHY AS, Grotz TE, Keeney GL, Glasgow AE, et al
    Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24430.
    PubMed     Abstract available


    June 2016
  82. CHANG TN, Lee CH, Lai CH, Wu CW, et al
    Profunda artery perforator flap for isolated vulvar defect reconstruction after oncological resection.
    J Surg Oncol. 2016;113:828-34.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: